Armed Forces Research Institute of Medical Sciences, Thailand
18
2
2
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
5.6%
1 terminated/withdrawn out of 18 trials
91.7%
+5.2% vs industry average
28%
5 trials in Phase 3/4
18%
2 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais With HIV Infection
Role: collaborator
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
Role: collaborator
Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and Youth
Role: collaborator
Household Influenza Transmission Study
Role: collaborator
Malaria Active Epidemiology and Treatment Study
Role: lead
Malaria Elimination Pilot Study in Military Forces in Cambodia
Role: lead
Drug Combinations of Atovaquone-Proguanil (AP) With ACT
Role: lead
The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia
Role: lead
Biomarkers of P. Vivax Relapse
Role: lead
HIV Vaccine Trial in Thai Adults
Role: collaborator
Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial
Role: collaborator
Malaria Prevention Cambodia
Role: lead
Harmonized AS/MQ Efficacy Study - Thailand
Role: lead
Study of Seasonal Influenza Vaccine Against H5N1 Avian Influenza Virus
Role: lead
Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh
Role: collaborator
Efficacy of Artesunate-Mefloquine Combination Therapy in Trat Province, Thailand
Role: lead
Artemisinin Resistance in Cambodia II
Role: lead
Artemisinin Resistance in Cambodia
Role: collaborator
All 18 trials loaded